Tech Company Financing Transactions

Element Biosciences Funding Round

Element Biosciences closed a $15 million Series A funding round on 6/19/2019. Investors included Foresite Capital, Venrock and private investors.

Transaction Overview

Company Name
Element Biosciences
Announced On
6/19/2019
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors

Foresite Capital (Lead Investor) (James Tananbaum)

Venrock (Lead Investor) (Bryan Roberts)

Proceeds Purpose
Proceeds from the financing will support the development of disruptive technologies designed to significantly improve quality and reduce the cost of genomic applications.

Company Information

Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
9880 Campus Point Dr. 210
San Diego, CA 92121
USA
Phone
(619) 353-0300
Website
www.elementbiosciences.com
Email Address
[email protected]
Overview
At Element, we innovate through a combination of cutting-edge technologies and established solutions. Our practices govern through a passion and fervor for rigorous science, such that data and results drive timely decisions in ever evolving markets. We take risks to challenge the status quo. We celebrate success and thrive in failures.
Profile
Element Biosciences LinkedIn Company Profile
Social Media
Element Biosciences Company Twitter Account
Company News
Element Biosciences News
Facebook
Element Biosciences on Facebook
YouTube
Element Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chairman
John Stuelpnagel
  John Stuelpnagel LinkedIn Profile  John Stuelpnagel Twitter Account  John Stuelpnagel News  John Stuelpnagel on Facebook
Chief Executive Officer
Molly He
  Molly He LinkedIn Profile  Molly He Twitter Account  Molly He News  Molly He on Facebook
Chief Technical Officer
Michael Previte
  Michael Previte LinkedIn Profile  Michael Previte Twitter Account  Michael Previte News  Michael Previte on Facebook
Vice President
Steve Potter
  Steve Potter LinkedIn Profile  Steve Potter Twitter Account  Steve Potter News  Steve Potter on Facebook
VP - Bus. Development
Jeffrey Journey
  Jeffrey Journey LinkedIn Profile  Jeffrey Journey Twitter Account  Jeffrey Journey News  Jeffrey Journey on Facebook
VP - Engineering
Francisco Garcia
  Francisco Garcia LinkedIn Profile  Francisco Garcia Twitter Account  Francisco Garcia News  Francisco Garcia on Facebook
VP - Finance
Logan Zinser
  Logan Zinser LinkedIn Profile  Logan Zinser Twitter Account  Logan Zinser News  Logan Zinser on Facebook
VP - General Counsel
David Melaugh
  David Melaugh LinkedIn Profile  David Melaugh Twitter Account  David Melaugh News  David Melaugh on Facebook
VP - Operations
Jeffrey Labbadia
  Jeffrey Labbadia LinkedIn Profile  Jeffrey Labbadia Twitter Account  Jeffrey Labbadia News  Jeffrey Labbadia on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/19/2019: RAPT Therapeutics venture capital transaction
Next: 6/19/2019: Joydrive venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.